Nathaniel S. Gardiner

2022

In 2022, Nathaniel S. Gardiner earned a total compensation of $2.4M as Senior Vice President and General Counsel at Enanta Pharmaceuticals, a 26% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$180,475
Option Awards$985,114
Salary$458,050
Stock Awards$739,664
Other$19,424
Total$2,382,727

Gardiner received $985.1K in option awards, accounting for 41% of the total pay in 2022.

Gardiner also received $180.5K in non-equity incentive plan, $458.1K in salary, $739.7K in stock awards and $19.4K in other compensation.

Rankings

In 2022, Nathaniel S. Gardiner's compensation ranked 1,526th out of 5,760 executives tracked by ExecPay. In other words, Gardiner earned more than 73.5% of executives.

ClassificationRankingPercentile
All
1,526
out of 5,760
74th
Division
Manufacturing
773
out of 3,136
75th
Major group
Chemicals And Allied Products
302
out of 1,422
79th
Industry group
Drugs
280
out of 1,323
79th
Industry
Pharmaceutical Preparations
199
out of 969
80th

Pay ratio

Nathaniel S. Gardiner's Pay$2,382,727
Median Employee's Pay$249,345
Pay Ratio

10

to 1

In 2022, the annual total compensation of Nathaniel S. Gardiner was $2,382,727.

The annual total compensation of the median employee at Enanta Pharmaceuticals was $249,345.

The ratio of Nathaniel S. Gardiner's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on January 20, 2023.

Gardiner's colleagues

We found four more compensation records of executives who worked with Nathaniel S. Gardiner at Enanta Pharmaceuticals in 2022.

2022

Jay Luly

Enanta Pharmaceuticals

Chief Executive Officer

2022

Scott Rottinghaus

Enanta Pharmaceuticals

Chief Medical Officer

2022

Yat Or

Enanta Pharmaceuticals

Chief Scientific Officer

2022

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

News

You may also like